Chief Financial Officer of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), Myszkowski Kenneth Allen, sells 30,625 shares worth $2,218,477
According to Arrowhead Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 07 06:08 PM, company Chief Financial Officer, Myszkowski Kenneth Allen disclosed selling 30,625 shares at a cost of $72.44. At the time of this transaction (Jan 06), this trade was worth $2,218,477 in total. As of Jan 06, Myszkowski Kenneth Allen now owns 457,043 shares in total worth about $36,321,207.21.
For the last few recent trades made by Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Chief Financial Officer, Myszkowski Kenneth Allen, we have the following information:
- SEC Form 4 filing: Nov 09: Sold 43,505 shares at the rate of $69.37 per share. Total worth of this trade was $3,018,071. Total number of shares owned as of Nov 09 were 427,668
- SEC Form 4 filing: Oct 20: Sold 29,166 shares at the rate of $54.04 per share. Total worth of this trade was $1,576,131. Total number of shares owned as of Oct 20 were 427,668
- SEC Form 4 filing: Jan 21: Sold 40,313 shares at the rate of $49.44 per share. Total worth of this trade was $1,992,925. Total number of shares owned as of Jan 21 were 384,223
Posted by
George Daniels
on Thursday January 07 2021, 6:24 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
